Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Dan Cerqueira Speaks at IBA’s 2024 Mergers and Acquisitions in Latin America Conference

March 15, 2024

On March 13, 2024, Cravath partner Daniel J. Cerqueira participated in the International Bar Association’s 2024 Mergers and Acquisitions in Latin America conference, which was jointly presented by the IBA Latin American Regional Forum and the IBA Corporate and M&A Law Committee, and held in Miami, FL. Dan spoke on a panel entitled “Artificial Intelligence in the M&A Process: Contracts Preparation, Due Diligence and Responsibility for Lawyers Using AI,” which reviewed AI’s impact on the M&A process, including how AI can potentially streamline and enhance the contract drafting and review process, and may raise ethical and professional considerations for lawyers leveraging this advanced technology.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Emerging and Founder-Led Companies
  • Technology

Speakers

Photo
Name
Daniel J. Cerqueira
Title
Corporate
Title
Partner
Email
dcerqueira@cravath.com
Phone
+1-212-474-1156
vCard
Download vCard

    Education

    • J.D., 2013, Harvard Law School
      magna cum laude
    • B.A., 2010, Cornell University
      Phi Beta Kappa

    Admitted In

    • New York

    Related News & Insights

    Deals & Cases

    February 01, 2024

    DRI Healthcare Trust’s Expansion of its Royalty Entitlement on the U.S. Net Sales of Omidria®

    On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.

    Deals & Cases

    August 15, 2023

    DRI Healthcare Trust’s Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU®

    On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.

    Deals & Cases

    August 08, 2023

    ESPN’s Agreement with PENN Entertainment to Launch ESPN BET

    On August 8, 2023, ESPN announced an agreement with PENN Entertainment (“PENN”) to launch ESPN BET, a branded sportsbook for fans in the United States. PENN Entertainment will rebrand its current sportsbook and relaunch as ESPN BET, effective this Fall in the 16 legalized betting states where PENN Entertainment is licensed. The rebrand includes the mobile app, website, and mobile website. In connection with the transaction, PENN Entertainment has agreed to grant ESPN warrants to purchase approximately 31.8 million PENN common shares that will vest ratably over 10 years, with the potential for ESPN to receive additional bonus warrants to purchase up to an additional approximately 6.4 million PENN common shares. ESPN is 80 percent owned by ABC, Inc., an indirect subsidiary of The Walt Disney Company. Cravath is representing The Walt Disney Company (“Disney”) in connection with the transaction.

    Deals & Cases

    August 04, 2023

    Hasbro’s Sale of its eOne Film and TV Business to Lionsgate

    On August 3, 2023, Hasbro, Inc., a leading toy and game company, announced that it has reached a definitive agreement to sell its eOne film and TV business to Lionsgate for approximately $500 million, consisting of $375 million in cash, subject to certain purchase price adjustments, and the assumption by Lionsgate of production financing loans. Cravath is representing Hasbro in connection with the transaction.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.